Profit Margin (Quarterly) Chart

Historical Profit Margin (Quarterly) Data

View and export this data back to 2000. Start Trial.
Date Value
June 30, 2026 18.89%
March 31, 2026 24.68%
December 31, 2025 15.35%
September 30, 2025 20.52%
June 30, 2025 17.22%
March 31, 2025 23.26%
December 31, 2024 11.34%
September 30, 2024 16.15%
June 30, 2024 14.63%
March 31, 2024 17.17%
December 31, 2023 10.41%
September 30, 2023 10.54%
June 30, 2023 5.82%
March 31, 2023 13.21%
December 31, 2022 6.24%
September 30, 2022 4.90%
June 30, 2022 4.02%
March 31, 2022 14.11%
December 31, 2021 6.92%
September 30, 2021 3.99%
June 30, 2021 -2.42%
March 31, 2021 12.44%
December 31, 2020 -3.13%
September 30, 2020 -2.59%
June 30, 2020 -1.30%
Date Value
March 31, 2020 9.00%
December 31, 2019 -3.28%
September 30, 2019 -1.89%
June 30, 2019 -8.66%
March 31, 2019 5.19%
December 31, 2018 -18.55%
September 30, 2018 -4.69%
June 30, 2018 -2.38%
March 31, 2018 3.19%
December 31, 2017 -20.84%
September 30, 2017 0.00%
June 30, 2017 -0.14%
March 31, 2017 0.25%
December 31, 2016 4.77%
September 30, 2016 6.19%
June 30, 2016 9.31%
March 31, 2016 14.50%
December 31, 2015 20.23%
September 30, 2015 9.30%
June 30, 2015 9.56%
March 31, 2015 13.69%
December 31, 2014 2.61%
September 30, 2014 4.98%
June 30, 2014 5.04%
March 31, 2014 15.79%

Profit Margin Definition

Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.

Read full definition.

Profit Margin (Quarterly) Range, Past 5 Years

View Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Profit Margin (Quarterly) Benchmarks

View Profit Margin (Quarterly) Benchmarks
Start Trial
Novo Nordisk A/S 26.74%
H. Lundbeck A/S 17.61%
AstraZeneca PLC 20.15%
ANI Pharmaceuticals, Inc. 8.65%
Corcept Therapeutics, Inc. 16.45%